Mon 5/20/2019 08:52 ET
S&P 5002859.5316.590.58%BANKS435.262.700.62%OIL62.840.080.13%BITCOIN7769.08402.445.18%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Stocks For A Different Jungle    If it belongs at the Pit it doesn't belong here.

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search
From: blacksheep (Rep: 331)Date: 06/12/2018 07:30
Forum: Stocks For A Different Jungle - Msg #19156Thread #674014627 (Rec: 0)

WuXi Biologics Inc. (HKSE:2269) said it will invest $60 million to construct a biologics production facility in Worcester, Mass. The manufacturing site will be WuXi Biologics' first in the U.S., and 11th overall.

The company plans to hire 150 employees at the site, where it will conduct clinical and small volume commercial production using single-use bioreactors. WuXi said the facility will be the first U.S. site with continuous bioprocessing capabilities, and will have an early stage bioprocess development lab.

Drawn primarily by scientific talent, Chinese biotechs are building beachheads in the Boston area to jump-start their push into novel drug development (see BioCentury, Sept. 29, 2017).

In addition to several China facilities, WuXi Biologics is constructing manufacturing sites in Singapore and Ireland.

WuXi Biologics raised HK$4 billion ($510 million) in a 2017 IPO (see BioCentury Extra, June 7, 2017).

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser blacksheep: Reward | Watch | Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999-, Inc.